Glaxo cuts price of HIV medicine
GlaxoSmithKline pledged to improve acess to HIV medicines by offering deep discounts to non-governmental organisations and employers that could distribute them efficiently in poor countries.
GlaxoSmithKline pledged to improve acess to HIV medicines by offering deep discounts to non-governmental organisations and employers that could distribute them efficiently in poor countries.